The Egypt Hypersomnia Therapeutics Market was valued at $14.95 Mn in 2023 and is predicted to grow at a CAGR of 5.73% from 2023 to 2030, to $22.08 Mn by 2030. The key drivers of this industry include the rising prevalence of sleep disorders, expanding geriatric population, early detection, and advancement in diagnostic tools. The key players in the industry are Delta Pharma, Teva, Sedico Pharmaceuticals, and Takeda Pharmaceuticals among others.
The Indonesia Conjunctivitis Therapeutics Market was valued at $25 Mn in 2022 and is predicted to grow at a CAGR of 5.4% from 2023 to 2030, to $37 Mn by 2030. The primary factors propelling this industry forward include the increasing prevalence of conjunctivitis, technological advancements, increasing government focus on preventative care, and others. The industry is primarily dominated by players such as Allergan, Bausch & Lomb, Alcon, Roche, Novartis, Santen, and Johnson & Johnson among others.
The US PET Scan Market was valued at $814.8 Mn in 2023 and is predicted to grow at a CAGR of 3.4% from 2023 to 2030, to $1029.7 Mn by 2030. The key drivers of the market include the rise in elderly population, increasing prevalence of chronic diseases, and increasing healthcare expenditure. The prominent players of the US PET Scan Market are GE Healthcare, Hitachi, Siemens Healthineers, Hologic, Toshiba, and Canon Medical Systems, among others.
Malaysia Dental Implant Market was valued at $8 Mn in 2023 and is predicted to grow at a CAGR of 10% from 2023 to 2030, to $15.60 Mn by 2030. The key drivers of this industry include rising demand for aesthetics, advanced dental technology, and high dental awareness. The industry is primarily dominated by Straumann Group, Dentsply Sirona, Zimmer Biomet Ltd, and Henry Schein Holdings Ltd among others.
The Kenya Hypersomnia Therapeutics Market was valued at $1.61 Mn in 2023 and is predicted to grow at a CAGR of 5.60% from 2023 to 2030, to $2.36 Mn by 2030. The key drivers of this industry include the rising prevalence of sleep disorders, expanding geriatric population, early detection, and advancement in diagnostic tools. The key players in the industry are Merck & Co., Sanofi SA, Johnson & Johnson, and GSK among others.
The Japan Conjunctivitis Therapeutics Market was valued at $255 Mn in 2022 and is predicted to grow at a CAGR of 5.9% from 2023 to 2030, to $403 Mn by 2030. The key drivers of this industry include the rising prevalence of conjunctivitis, technological advancements in the industry, and growing consumer demand for effective treatments. The industry is primarily dominated by players such as Allergan, Bausch & Lomb, Roche, Novartis, Santen, and Johnson & Johnson among others.
The Saudi Arabia PET Scan Market was valued at $33 Mn in 2023 and is predicted to grow at a CAGR of 6.9% from 2023 to 2030, to $52.6 Mn by 2030. The key drivers of the market include increased healthcare expenditure, increased geriatric population, and rising prevalence of chronic diseases. The prominent players of the Saudi Arabia PET Scan Market are Philips Healthcare, Toshiba Medical Systems, Hitachi Medical Systems, Shimadzu, and Mediso Medical Imaging Systems, among others.
Philippines Dental Implant Market was valued at $11 Mn in 2023 and is predicted to grow at a CAGR of 10.3% from 2023 to 2030, to $21.80 Mn by 2030. The key drivers of this industry include rising demand for aesthetics, growing dental tourism potential, and high dental awareness. The industry is primarily dominated by Straumann Group, Dentsply Sirona, Zimmer Biomet Ltd, and Henry Schein Holdings Ltd among others.
The South Africa Hypersomnia Therapeutics Market was valued at $57.50 Mn in 2023 and is predicted to grow at a CAGR of 5.50% from 2023 to 2030, to $83.64 Mn by 2030. The key drivers of this industry include the rising prevalence of sleep disorders, expanding geriatric population, early detection, and advancement in diagnostic tools. The key players in the industry are Cipla Medpro, Novartis, Pfizer, and Sanofi among others.
The Kenya Conjunctivitis Therapeutics Market was valued at $3 Mn in 2022 and is predicted to grow at a CAGR of 6.5% from 2023 to 2030, to $5 Mn by 2030. The key drivers of this industry include the rising prevalence of conjunctivitis, the growing pharmaceutical industry, and supportive government initiatives. The industry is primarily dominated by players such as Allergan, Novartis, Sirion, Boehringer Ingelheim, Pfizer, and others.
The UAE PET Scan Market was valued at $9.7 Mn in 2023 and is predicted to grow at a CAGR of 6.4% from 2023 to 2030, to $15 Mn by 2030. The key drivers of the market include the rise in elderly population, increasing prevalence of chronic diseases, and increasing healthcare expenditure. The prominent players of the UAE PET Scan Market are Philips Healthcare, Toshiba Medical Systems, Hitachi Medical Systems, Shimadzu, and Mediso Medical Imaging Systems, among others.
The India Hypersomnia Therapeutics Market was valued at $34.50 Mn in 2023 and is predicted to grow at a CAGR of 4.75% from 2023 to 2030, to $47.74 Mn by 2030. The key drivers of this industry include increasing awareness, lifestyle changes, expanding geriatric population, and early detection. The key players in the industry are Cipla, Lupin, Abbott India, Teva Pharmaceuticals, and Jazz Pharmaceuticals among others.
The Malaysia Conjunctivitis Therapeutics Market was valued at $7 Mn in 2022 and is predicted to grow at a CAGR of 5.6% from 2023 to 2030, to $10 Mn by 2030. The key drivers of this industry include the surge in the burden of conjunctivitis, technological advancements in the industry, and supportive government initiatives. The industry is primarily dominated by players such as Bausch & Lomb, Roche, Novartis, AstraZeneca, and Johnson & Johnson among others.
The Brazil PET Scan Market was valued at $48.5 Mn in 2023 and is predicted to grow at a CAGR of 6.4% from 2023 to 2030, to $74.9 Mn by 2030. The key drivers of the market include the rising prevalence of chronic diseases, rising demand for non-invasive diagnostic devices, and increased demand for early diagnosis. The prominent players of the Brazil PET Scan Market are Philips Healthcare, Toshiba Medical Systems, Hitachi Medical Systems, Shimadzu, and Mediso Medical Imaging Systems, among others.
Vietnam Dental Implant Market was valued at $24.90 Mn in 2023 and is predicted to grow at a CAGR of 10.03% from 2023 to 2030, to $48.70 Mn by 2030. The key drivers of this industry include rising demand for aesthetics, growing dental awareness, and advanced dental infrastructure. The industry is primarily dominated by Straumann Group, Dentsply Sirona, Zimmer Biomet Ltd, and Henry Schein Holdings Ltd among others.
The France Head and Neck Cancer Therapeutics Market was valued at $6.10 Mn in 2023 and is predicted to grow at a CAGR of 12.73% from 2023 to 2030, to $14.11 Mn by 2030. The key drivers of this industry include advancement in treatment, government initiatives, and investment in R&D. The industry is primarily dominated by players such as Sanofi, Roche, Merck & Co., and AstraZeneca among others.
The Mexico Conjunctivitis Therapeutics Market was valued at $62 Mn in 2022 and is predicted to grow at a CAGR of 5.65% from 2023 to 2030, to $95 Mn by 2030. The key drivers of this industry include the increasing incidence of conjunctivitis, growing demand for eye care, and pharmaceutical innovation in the industry. The industry is primarily dominated by players such as Novartis, Pfizer, Bausch & Lomb, Sanofi, Santen, Allergan, and AbbVie among others.
The Mexico PET Scan Market was valued at $29.1 Mn in 2023 and is predicted to grow at a CAGR of 5.65% from 2023 to 2030, to $42.8 Mn by 2030. The key drivers of the market include increased healthcare expenditure, increased geriatric population, and rising prevalence of chronic diseases. The prominent players of the Mexico PET Scan Market are GE Healthcare, Hitachi, Siemens Healthineers, Toshiba, and Canon Medical Systems, among others.
Egypt Dental Implant Market was valued at $14 Mn in 2023 and is predicted to grow at a CAGR of 11.3% from 2023 to 2030, to $29.60 Mn by 2030. The key drivers of this industry include rising demand for aesthetics, growing dental awareness, and advanced dental infrastructure. The industry is primarily dominated by Straumann Group, Dentsply Sirona, Zimmer Biomet Ltd, and Henry Schein Holdings Ltd among others.
The Germany Head and Neck Cancer Therapeutics Market was valued at $2.68 Mn in 2023 and is predicted to grow at a CAGR of 13% from 2023 to 2030, to $6.31 Mn by 2030. The key drivers of this industry include advancement in treatment, rising incidence, and an aging population. The industry is primarily dominated by players such as Bristol Myers Squibb, Merck, Pfizer, and AstraZeneca among others.
The Philippines Conjunctivitis Therapeutics Market was valued at $9 Mn in 2022 and is predicted to grow at a CAGR of 5.9% from 2023 to 2030, to $14 Mn by 2030. The key drivers of this industry include the rising prevalence of conjunctivitis, technological advancements in the industry, and rising disposable income. The industry is primarily dominated by players such as Allergan, Bausch & Lomb, Novartis, Rohto, Santen, and Johnson & Johnson among others.
The France PET Scan Market was valued at $53.4 Mn in 2023 and is predicted to grow at a CAGR of 4.4% from 2023 to 2030, to $72.1 Mn by 2030. The key drivers of the market include the rising prevalence of chronic diseases, rising demand for non-invasive diagnostic devices, and increased demand for early diagnosis. The prominent players of the France PET Scan Market are GE Healthcare, Hitachi, Siemens Healthineers, Toshiba, and Canon Medical Systems, among others.
Kenya Dental Implant Market was valued at $3.50 Mn in 2023 and is predicted to grow at a CAGR of 10.9% from 2023 to 2030, to $7.20 Mn by 2030. The key drivers of this industry include rising demand for aesthetics, a growing geriatric population, and increasing demand for cosmetic dentistry. The industry is primarily dominated by Straumann Group, Dentsply Sirona, Zimmer Biomet Ltd, and Henry Schein Holdings Ltd among others.
The Spain Head and Neck Cancer Therapeutics Market was valued at $1.46 Mn in 2023 and is predicted to grow at a CAGR of 13.10% from 2023 to 2030, to $3.47 Mn by 2030. The key drivers of this industry include advancement in treatment, increasing incidence, and growing awareness. The industry is primarily dominated by players such as Bristol Myers Squibb, Merck, Roche, and Pfizer among others.
The Germany PET Scan Market was valued at $71 Mn in 2023 and is predicted to grow at a CAGR of 3.6% from 2023 to 2030, to $91 Mn by 2030. The key drivers of the market include expanding applications in medical field, rising advantages over other imaging techniques, and technological advancements. The prominent players of the Germany PET Scan Market are Siemens Healthineers, GE Healthcare, Hitachi, Medical Imaging Electronics (MiE), and Canon Medical Systems, among others.